Potential involvement of a propranolol-insensitive atypical β-adrenoceptor in the vasodilator effect of cyanopindolol in the human pulmonary artery

Journal of Physiology and Pharmacology

Volumn 57, Issue 3, 2006, Pages 317-328

  Kozłowska, Hanna ^a   Schlicker, E ^b   Kozlowski M ^a   Baranowska, M ^a   Malinowska, B ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

Atypical adrenoceptors; Bupranolol; CGP 20712; Cyanopindolol; Human pulmonary artery; Low affinity state of the 1 adrenoceptor

Indexed keywords

5 [2 [[2 HYDROXY 3 [4 (1 METHYL 4 TRIFLUOROMETHYL 2 IMIDAZOLYL)PHENOXY]PROPYL]AMINO]ETHOXY]SALICYLAMIDE; BETA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BETA ADRENERGIC RECEPTOR; BUPRANOLOL; CYANOPINDOLOL; KETANSERIN; PHENYLEPHRINE; PRAZOSIN; PROPRANOLOL; SEROTONIN;

ADULT; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENCY; FEMALE; HUMAN; HUMAN TISSUE; MALE; MESENTERIC ARTERY; PULMONARY ARTERY; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ANALYSIS OF VARIANCE; BUPRANOLOL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; IMIDAZOLES; MALE; MIDDLE AGED; PINDOLOL; PULMONARY ARTERY; RECEPTOR, SEROTONIN, 5-HT2A; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; VASOCONSTRICTION; VASODILATION; VASODILATOR AGENTS;

EID: 33749618099     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Guimaraes S, Moura D. Vascular adrenoceptors: an update. Pharmacol Rev 2001; 53: 319-356.
2. 1-adrenoceptors, relax the rat isolated mesenteric artery. Br J Pharmacol 2003; 140: 3-12.
3. 1-adrenoceptors-mediated constriction in human pulmonary and rat mesenteric artery. J Cardiovasc Pharmacol 2005; 46: 76-82.
4. Alexander SPH, Mathie A, Peters JA. 7 TM receptors. In: Guide to Receptors and Channels, SPH Alexander, A Mathie, JA Peters (eds). Br J Pharmacol 2004; 141: S10.
5. Kaumann AJ, Molenaar P. Modulation of human cardiac function through 4 beta-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 1997; 355: 667-681.
6. 3-adrenoceptors mediate vasorelaxation of human coronary microarteries through nitric oxide and endothelium-dependent hyperpolarization. Circulation 2004; 110: 948-954.
7. Rozec B, Serpillon S, Toumaniantz G et al. Characterization of beta3-adrenoceptors in human internal mammary artery and putative involvement in coronary artery bypass management. J Am Coll Cardiol 2005; 46: 351-359.
8. 3-adrenergic receptor activation via cyclic GMP- but not NO-dependent mechanisms in human corpus cavernosum function. Proc Natl Acad Sci U S A 2003; 100: 5531-5536.
9. 3-adrenoceptor agonists: Human myometrial selectivity and effects on umbilical artery tone. Am J Obstet Gynecol 2002; 187: 641-647.
10. Barnes PJ, Liu SF. Regulation of pulmonary tone. Pharmacol Rev 1995; 47: 87-131.
11. Carstairs JR, Nimmo AJ, Barnes PJ. Autoradiographic visualization of beta-adrenoceptors subtypes in human lung. Am Rev Respir Dis 1985; 132: 541-547.
12. Peng HL, Jiang MH, Yang ZC. Determination of beta-adrenoceptor subtypes in human pulmonary artery and thoracic artery by radioligand binding. Zhongguo Yao Li Xue Bao 1993, 14: 298-301.
13. Boe J, Simonsson BG. Adrenergic receptors and sympathetic agents in isolated human pulmonary arteries. Eur J Respir Dis 1980; 61: 195-202.
14. Tamaoki J, Tagaya E, Isono K, Nagai A. Atypical adrenoceptor-mediated relaxation of canine pulmonary artery through a cAMP-dependent pathway. Biochem Biophys Res Commun 1998; 248: 722-727.
15. 3-adrenoceptor antagonist, SR 59230A. Eur J Pharmacol 1998; 348: 223-228.
16. 3-AR and endothelial nitric oxide, in β-AR-mediated relaxation of rat intrapulmonary artery. Naunyn Schmiedebergs Arch Pharmacol 2005; 372: 14-23.
17. 2- adrenergic receptors. Mol Pharmacol 2001; 60: 955-962.
18. 3-adrenoceptor in the rat. Br J Pharmacol 1996; 118: 2085-2098.
19. 3-adrenoceptors. Br J Pharmacol 1996; 117: 943-949.
20. MacLean MR, Herve P, Eddahibi S, Adnot S. 5-Hydroxytryptamine and the pulmonary circulation: receptors, transporters and relevance to pulmonary arterial hypertension. Br J Pharmacol 2000; 131: 161-168.
21. Malinowska B, Kieć-Kononowicz K, Flau K et al. Atypical cardiostimulant β-adrenoceptor in the rat heart: stereoselective antagonism by bupranolol but lack of effect by some bupranolol analogues. Br J Pharmacol 2003; 139: 1548-1554.
22. 1- adrenoceptors and interaction with β-blockers. Naunyn Schmiedebergs Arch Pharmacol 2004; 369: 525-532.
23. 3-adrenoceptors in the pithed rats. Br J Pharmacol 1997; 122: 1307-1314.
24. 1-adrenoceptor. Mol Pharmacol 2003; 63: 1312-1321.
25. 1B binding sites. Naunyn Schmiedebergs Arch Pharmacol 1986; 332: 1-7.
26. 3- or atypical β-adrenoceptors in rat aorta. Br J Pharmacol 2004; 142: 781-787.
27. 2C receptors. Naunyn Schmiedebergs Arch Pharmacol 2004; 370: 114-123.
28. 1-adrenoceptor. Naunyn Schmiedebergs Arch Pharmacol 2003; 367: 10-21.